Health AI's Wild West: Big Law's Race to Recruit Regulatory Insiders

WASHINGTON & SEATTLE – July 15, 2026

The relentless march of technology into healthcare has long promised a revolution in patient outcomes and operational efficiency. But as artificial intelligence and digital health tools move from the lab to the clinic, they are creating an equally revolutionary challenge: a legal and regulatory landscape so complex and fast-moving that it resembles a new frontier. In this high-stakes environment, top-tier law firm Wilson Sonsini Goodrich & Rosati has made a significant move, signaling a broader industry trend by adding two deeply specialized attorneys, Brandon Ge and Ty Kayam, to its healthcare regulatory practice. These hires are not just a routine expansion; they are a strategic response to an industry grappling with the immense pressures of innovating faster than regulation can keep pace.

“A successful health innovation and AI strategy requires a sound data and regulatory approach,” said Jodi Daniel, chair of Wilson Sonsini's Healthcare Regulatory practice. The firm's expansion in Washington, D.C., and Seattle is a direct answer to what it calls “growing client demand for integrated counsel” across a minefield of modern legal challenges: health data privacy, cybersecurity, AI governance, and U.S. Food and Drug Administration (FDA) matters.

A Regulatory Maze in the Making

The demand for such expertise is not speculative. The U.S. digital health market is exploding, projected to be worth up to $95 billion by next year. Fueling this growth is the rapid adoption of AI, with the FDA having authorized over 1,400 AI- and machine learning-enabled medical devices by the end of 2025—a staggering increase from just a handful a decade ago. This torrent of innovation is colliding with a fragmented and reactive regulatory system.

Internationally, the European Union’s AI Act, enacted in 2024, set a high bar by classifying most AI medical devices as “high-risk.” In the U.S., the FDA is playing catch-up, developing new guidelines for how AI systems are managed throughout their lifecycle. Meanwhile, a “patchwork quilt” of state-level laws is emerging, with nearly every state having introduced AI-related legislation. This creates a bewildering compliance map for any company operating nationwide.

Compounding the complexity is a parallel crisis in cybersecurity. In 2024 alone, ransomware attacks on healthcare organizations surged by 264%, exposing the data of over 276 million individuals. While modernizations to the bedrock of U.S. health privacy, the Health Insurance Portability and Accountability Act (HIPAA), are in the works, final action has been delayed, leaving innovators to navigate a landscape of escalating threats with aging rules.

The Rise of the Regulatory Super-Specialist

To navigate this maze, companies are seeking a new kind of legal guide—one who has not only read the map but helped draw it. This is where the strategic value of hires like Ty Kayam and Brandon Ge becomes clear, representing a broader “talent arms race” among elite law firms for regulatory insiders.

Ty Kayam, who joins as Of Counsel in Seattle, brings a uniquely powerful perspective. She was the very first attorney to serve in the FDA’s Digital Health Center of Excellence, where she was instrumental in shaping the agency’s approach to software and AI-enabled medical technologies. Her work on policies like Predetermined Change Control Plans (PCCPs)—which allow for pre-approved AI updates without a full re-review—gives her an unparalleled insider’s view. Before her government service, Kayam was senior corporate counsel at Microsoft, advising teams developing health technologies that incorporated generative AI. This dual experience, spanning both the regulator and the regulated, is a rare and invaluable commodity.

“Regulatory strategy for a health technology product cannot be separated from how the product is designed and deployed,” Kayam noted. “Having worked on both sides of the table, I’ve seen how early choices shape regulatory and market readiness.”

Similarly, Brandon Ge, the new senior counsel in Washington, D.C., brings expertise that speaks directly to the market’s primary anxieties: data privacy and transactional risk. He specializes in HIPAA, the FTC Act, and a web of state and international privacy laws. Crucially, he has led privacy and security due diligence for major healthcare and technology transactions, including acquisitions by one of the nation’s largest health insurers and a multibillion-dollar deal by a global tech giant. His experience underscores a fundamental shift in corporate strategy.

“Companies used to address privacy and cybersecurity after a deal closed, or after an incident,” Ge observed. “That has changed fundamentally—these issues now influence how health technology companies build products, which transactions move forward and on what terms, and how companies respond to regulatory scrutiny.”

Proactive Compliance: The New Price of Entry

The insights from Kayam and Ge illuminate the new imperative for success in health technology: proactive compliance. The old model of innovating first and asking for legal forgiveness later has become untenable. In today's climate, integrating regulatory strategy from the earliest stages of product development is no longer a best practice but the price of entry. Building trust with consumers, investors, and regulators is now a core component of product design.

This shift is reflected across the legal industry. Wilson Sonsini’s competitors, including firms like Latham & Watkins, Cooley, and Goodwin Procter, are also aggressively building out their digital health and AI practices, often by recruiting talent with similar government or deep industry experience. According to one legal industry analyst, the demand for attorneys who can fluently speak the languages of technology, medicine, and regulation has created a hyper-competitive market for a very small pool of talent.

For health tech founders and the venture capitalists who back them, the message is clear. A brilliant algorithm or a sleek wearable is not enough. Success requires a sophisticated understanding of a legal and ethical framework that is being built in real time. The ability to demonstrate robust governance, ensure data integrity, and navigate a multi-jurisdictional regulatory system is now a key differentiator that determines market access, enterprise partnerships, and ultimately, survival.

As innovation continues to accelerate, the line between legal counsel and strategic business advisor will only continue to blur, making the acquisition of deep, insider knowledge a critical pillar for any organization hoping to lead in the new era of intelligent health.